Zhengye Biotechnology
(NASDAQ) ZYBT
Zhengye Biotechnology Financials at a Glance
Market Cap
$22.92MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
N/A
Net Income (TTM)
N/A
EPS (TTM)
-$0.21
P/E Ratio
-3.75
Dividend
$0.00
Beta (Volatility)
1.50 (High)
Dividend
$0.00
Beta (Volatility)
1.50 (High)
Price
$0.79
Volume
40
Open
$0.79
Price
$0.79
Volume
40
Open
$0.79
Previous Close
$0.77
Daily Range
$0.79 - $0.79
52-Week Range
$0.62 - $13.08
Estimated Earnings Date
N/A
Dividend
$0.00
Beta (Volatility)
1.50 (High)
Price
$0.79
Volume
40
Open
$0.79
Previous Close
$0.77
Daily Range
$0.79 - $0.79
52-Week Range
$0.62 - $13.08
Estimated Earnings Date
N/A
ZYBT News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Zhengye Biotechnology
Industry
Pharmaceuticals
Sector
Health CareEmployees
269
CEO
Aiden Han; Song Lin Song
Website
www.jlzybio.comHeadquarters
Jilin, JI 132101, CN
ZYBT Financials
Key Financial Metrics (TTM)
Gross Margin
20.51%
Operating Margin
-58.66%
Net Income Margin
-59.97%
Return on Equity
-26.15%
Return on Capital
-21.01%
Return on Assets
-15.99%
Earnings Yield
-26.67%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$22.92MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
29.73M
Volume
40
Avg. Volume
104.70K
Financials (TTM)
Gross Profit
CN¥4.40M
Operating Income
-CN¥40.86M
EBITDA
-CN¥27.41M
Operating Cash Flow
CN¥26.55M
Capital Expenditure
-CN¥743.56K
Free Cash Flow
CN¥25.81M
Cash & ST Invst.
CN¥51.89M
Total Debt
CN¥75.08M
Zhengye Biotechnology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
CN¥53.04M
N/A
Gross Profit
CN¥4.40M
N/A
Gross Margin
8.30%
N/A
Market Cap
$22.92MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$82.44K
N/A
Employees
278
N/A
Net Income
-CN¥47.23M
N/A
EBITDA
-CN¥27.41M
N/A
Quarterly Fundamentals
Total Cash
CN¥51.89M
+218.4%
Total Debt
CN¥75.08M
-16.4%
Accounts Receivable
CN¥18.49M
-81.4%
Inventory
CN¥39.17M
-32.8%
Long Term Debt
CN¥9.18M
-8.1%
Short Term Debt
CN¥65.91M
-17.5%
Return on Assets
-15.99%
N/A
Return on Invested Capital
-21.60%
N/A
Free Cash Flow
CN¥25.81M
N/A
Operating Cash Flow
CN¥26.55M
N/A